Company Short-Term Debts: Milestone Scientific (MLSS)

Milestone Scientific Corporation (MLSS) - corporate logo

The short-term debt development trend for Milestone Scientific (MLSS), based on GURU.Markets data, currently stands at 0.00. Diversifying the sales of painless injection systems into dentistry and cosmetology stabilizes the cash flow. The company achieves cost optimization through contract electronics manufacturing and outsourced services. However, the slow adoption of technologies into clinical practice limits revenue, creating certain cash flow pressures.

MLSS (Milestone Scientific Inc.) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for Milestone Scientific Corporation (MLSS)

- price and consensus price forecast:
Stock Price Milestone Scientific Inc.|MLSS - Analyst Median Target
- market capitalization data:
Market Capitalization Milestone Scientific Inc.|MLSS - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Milestone Scientific|MLSS - Book Capitalization|Market Value to Book Value Ratio milestonescientific.com|MLSS - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Milestone Scientific|MLSS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Milestone Scientific|MLSS - Company Total Debt Obligations|Debt to Book Capitalization Ratio Milestone Scientific Inc.|MLSS - Company Long-Term Indebtedness|Company Short-Term Debt Milestone Scientific
Fundamental company valuation:Milestone Scientific
Signature product of Milestone Scientific Corporation

The complexity of implementing patented DPS anesthesia systems due to dentist conservatism requires significant operational resources from Milestone Scientific (MLSS). An analysis of changes in short-term liabilities allows for an assessment of debt maturing within one year, revealing liquidity risks and the company's ability to service current loans without compromising strategic business development.

Competitor analysis for Milestone Scientific

Company Short-Term Debts ISRG (Intuitive)|DHR - Short-Term Debt Volume|BDX (Becton, Dickinson and Company) - Company Short-Term Debts|STERIS Group (STE) - Company Current Liabilities|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts BAX|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt Stevanato Group SpA STVN|Company Current Liabilities Teleflex Inc|Company Short-Term Loans and Borrowings Merit Medical Corp MMSI|Company Short-Term Debts NVST (Envista Holdings)|ICUI: Short-Term Debt Volume|Company Short-Term Debt Dentsply Sirona|LMAT (LeMaitre Vascular Inc) - Company Short-Term Indebtedness|ATRC: Company Short-Term Debt|Short-Term Debt Volume STAAR Surgical Co (STAA)|Company Current Liabilities ChromaDex|Amount of Current Liabilities ZIMV (zimvie.com)|Company Short-Term Debt AngioDynamics|CERS - Company Short-Term Loans and Borrowings|Alpha Teknova Inc - Company Current Liabilities|MGRM: Company Short-Term Debts|STSS (sharpstechnology.com) - Company Short-Term Debt|InfuSystem Holdings, Inc. (INFU) - Company Current Liabilities|Company Short-Term Debts UTMD (Utah Medical Products, Inc.)|Short-Term Debt KRMD|Company Short-Term Debt Nyxoah, S.A. NYXH|Company Short-Term Indebtedness Microbot Medical, Inc MBOT|Company Current Liabilities Pro-Dex, Inc. (PDEX)|zentek.com - Amount of Current Liabilities|Company Short-Term Debt ELUT (Elutia)|NXGL: Short-Term Debt Volume|RVP (retractable.com) - Company Short-Term Debt|Harvard Bioscience Inc. (HBIO) - Company Current Liabilities|FEMY: Company Short-Term Debts|Short-Term Debt Volume MHUA|Company Short-Term Debt Predictive Oncology (POAI)|Company Short-Term Debt callanjmb.com (CJMB)|ATRI: Company Short-Term Debts|NeuroMetrix Corporation - Short-Term Debt